Goldman Sachs
ACUR

Goldman Sachs’s Acura Pharmaceuticals ACUR Stock Holding History

Goldman Sachs’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,237
Closed -$11K – 7651
2015
Q2 		$11K Buy
+2,237
New +$9.29K ﹤0.01% 7150
2015
Q1 		– Sell
-8,378
Closed -$19K – 7449
2014
Q4 		$19K Buy
8,378
+3,598
+75% +$9.95K ﹤0.01% 6996
2014
Q3 		$19K Sell
4,780
-170
-3% -$798 ﹤0.01% 6994
2014
Q2 		$27K Buy
4,950
+544
+12% +$3.3K ﹤0.01% 6845
2014
Q1 		$32K Sell
4,406
-40
-0.9% -$347 ﹤0.01% 6641
2013
Q4 		$37K Sell
4,446
-2,626
-37% -$22.2K ﹤0.01% 6474
2013
Q3 		$67K Buy
7,072
+2,379
+51% +$21K ﹤0.01% 6258
2013
Q2 		$44K Buy
+4,693
New +$53K ﹤0.01% 6079

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return

Goldman Sachs's ACUR Position: Q3 2015 in Review

Goldman Sachs sold out of Acura Pharmaceuticals (ACUR) in Q3 2015, closing a stake of 2,237 shares — an estimated $11K sold.

Goldman Sachs first reported a position in ACUR in Q2 2013 and held it in 8 quarters. The position peaked at $67K in Q3 2013. 22 funds tracked by Wall St. Rank hold ACUR as of Q3 2015.

  • Goldman Sachs reported no remaining Acura Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Goldman Sachs sold 2,237 Acura Pharmaceuticals shares in Q3 2015, an estimated $11K.
  • Goldman Sachs first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Goldman Sachs's Acura Pharmaceuticals position peaked at $67K in Q3 2013.
  • 22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2015.

Based on Goldman Sachs's 13F filing for Q3 2015, filed 13 Nov 2015.